Star Health and Allied Insurance just delivered a quarter that makes you sit up and take notice.
That is a 233% jump, but the headline number only tells part of the story. Investor Presentation
The real story lies in what drove this surge. Underwriting profit swung from a loss of ₹40 crore to a profit of ₹99 crore. The combined ratio improved to 98% from 100.9%. The claims ratio dropped to 69% from 71.5%. Investment income climbed 62% to ₹268 crore, with the annualised yield rising to 4.9% from 3.6%. Investor Presentation
These are not just random improvements. They reflect a deliberate strategy that management believes positions the company well for what is coming next from the Insurance Regulatory and Development Authority of India (IRDAI).
On September 23, IRDAI released a consultation paper titled "Recalibrating Economics of Insurance Distribution". The paper proposes significant changes to how insurers manage their expenses and pay commissions.
For general insurers, the proposal includes a glide path to lower the Expense of Management (EoM) limit to 25% within two years and 20% within five years. The 2023 carve-outs would be absorbed into this overall limit. The paper also proposes bringing back prescriptive commission caps, with lower caps for open-architecture distributors than for agents engaged directly by insurers.
This is where Star Health's positioning becomes interesting. The company is not just reacting to these proposals. It is actively shaping the conversation.
During the post-earnings call with analysts, Star Health made a specific request to the regulator. It wants motor third-party insurance and government-sponsored health schemes excluded from the base used to determine EoM limits.
The logic is straightforward. Government health programmes should ideally come at zero cost, so counting such business blurs what insurers actually spend on selling retail policies. When you mix low-cost mandated covers with voluntary retail business, the blended expense ratio does not reflect the true cost of acquiring retail customers.
This matters more for multi-line general insurers, which write far more motor third-party, crop and government scheme business than Star Health does. Their expense ratios would otherwise be judged on a mix that includes these low-cost mandated covers.
Star Health, as a standalone health insurer, has minimal exposure to these products. Its book is mostly retail health. The company argues that excluding mandated covers would create a like-for-like comparison and show what insurers actually spend on voluntary retail policies.
Here is where Star Health's distribution strategy becomes a key differentiator.
Over 90% of its retail business comes through its own agents and its direct-to-customer channel.
This proprietary mix gives Star Health leverage over customer selection, sales quality and acquisition economics. When the regulator proposes changes to commission structures, Star Health can adjust its own agent payouts without negotiating with banks, brokers or aggregators. Transcript
The mechanism is simple. Today, front-loaded first-year commissions reward a distributor for moving a policyholder to a new insurer, even if the customer gains nothing. If a larger part of the payout depends on renewals, switching earns less and the distributor gains from keeping the customer with one insurer.
This suits Star Health's agent-led model. Agents hold the customer relationship and benefit from renewals. Channels that depend on switching and churn lose more.
The data supports this. Star Health's renewal ratio rose to 102% in Q1 FY27. Management said portability has come down and that new-to-industry customers are about 94–95% of the mix. Transcript +1
Roy said several proposals in the consultation paper are "well aligned with our distribution footprint". These include higher commissions for business from smaller towns and rural areas, and a requirement that an agent represent only one insurer within a product segment.
Star Health has been building this footprint for years. Today, 50% of its business comes from Tier-II and Tier-III cities, and it wants to take this to at least 60–65% in the next three years. Fresh business growth from non-metro geographies is 3.5 times the growth in metro geographies. Transcript
Roy said rural operating costs are low and ticket sizes are similar to urban. A higher commission band for small towns and rural areas would raise agent income where Star Health already has a presence, while costing less in EoM terms than it would for an insurer that is mostly metro-based.
The paper proposes a 2% cap on commissions for single-premium life cover packaged with loans. Commissions averaged 22% in FY25, and effective payouts on NBFC group credit life were around 45%. Credit life makes up roughly a third of ICICI Life's protection business.
The difference follows from who earns the commission. Star Health pays its own agents and can reshape that pay. Credit life commissions go largely to lenders, so a cap changes the lender's incentive to sell the product.
The ₹99 crore underwriting profit in Q2 FY27 is a thin buffer. In Q1 FY27, the underwriting result was ₹111 crore, so Q2 is lower sequentially. Net profit also fell from ₹549.74 crore in Q1 to ₹264.81 crore in Q2 [stock_agent]. Transcript
Management said its internal estimates show a credible path to meeting the proposed EoM limits, helped by digital automation and higher agent productivity. The company is probably the only standalone health insurer already operating within current EoM limits. Transcript
But sustainability depends on more than just underwriting. Investment income contributed significantly to the profit surge, rising 62% year-on-year. This is market-dependent, not regulation-dependent. Investor Presentation
Management said about 80% of the book was repriced in the last cycle, with the rest being taken up this year. The insurer has no immediate plans to cut premiums in response to the regulator's push on affordability and will wait for the final regulations before taking a call.
This repricing feeds through as policies renew, supporting margins in coming quarters. But once the remaining 20% renews, the next lever is limited. If medical inflation rises, repricing room may be narrow.
Roy also flagged that headline growth will slow in the second half, as last year's surge in demand after the GST exemption on retail health premiums becomes part of the base. The company aims to grow fresh business by more than 20% over the long term.
Retail fresh premium rose 36% to ₹1,630 crore in the first half, with 93% of new customers buying health insurance for the first time. Only about 60 million Indians hold retail health insurance, against a population of 1.5 billion. The growth opportunity is multi-decadal.
Star Health's Q2 profit surge is impressive, but the more important story is its regulatory positioning. The agent-led model, minimal exposure to mandated products, and focus on underwriting profitability give it insulation from the proposed expense caps and distribution reforms.
The ₹99 crore underwriting profit shows the strategy is working. The 8.7 lakh agent network, with 85.3% of gross premium coming through agencies, provides the distribution muscle to sustain growth.
The question is whether this positioning will hold once IRDAI finalises the regulations. The consultation paper is still a draft, and comments were due by October 25. The final impact on margins, growth and agent income will depend on what IRDAI ultimately implements.
For now, Star Health is betting that its focused health model and agent-led distribution will be assets, not liabilities, in the new regulatory regime. The early signs suggest it might be right.
